Cited by 132Treatment of Major DepressionNeurotransmitter Receptor Influence on BehaviorNerve injury and regeneration

Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions

Open access
Molteni, Raffaella, Calabrese, Francesca, Bedogni, Francesco, Tongiorgi, Enrico, Fumagalli, Fabio, Racagni, Giorgio, Andrea Riva, Marco·2006·The International Journal of Neuropsychopharmacology

Abstract

During the last few years several studies have highlighted the possibility that major depression can be characterized by a general reduction in brain plasticity and an increased vulnerability under challenging situations. Such dysfunction may be the consequence of reduced expression and function of proteins important for neuroplasticity such as brain-derived neurotrophic factor (BDNF). On this basis, by using a sensitive non-radioactive in-situ hybridization, we evaluated the effects of a chronic treatment with fluoxetine on BDNF expression within rat dopaminergic regions. In fact, besides the well-established role of the hippocampus, increasing evidence indicates that other brain regions may be involved in the pathophysiology of depression and consequently be relevant for the therapeutic action of antidepressant drugs. Our results indicate that 3 wk of fluoxetine administration up-regulates BDNF mRNA levels selectively within structures belonging to the meso-cortico-limbic pathway. The expression of the neurotrophin is significantly increased in the ventral tegmental area, prefrontal cortex, and shell region of the nucleus accumbens, whereas no changes were detected in the substantia nigra and striatum. Moreover, in agreement with previous studies, fluoxetine increased BDNF mRNA levels in the hippocampus, an effect that was limited to the cell bodies without any change in its dendritic targeting. These data show that chronic treatment with fluoxetine increases BDNF gene expression not only in limbic areas but also in dopaminergic regions, suggesting that such an effect may contribute to improve the function of the dopaminergic system in depressed subjects.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s1461145705005766

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Fluoxetine induces the expression of BDNF in dentate gyrus cells, where it exerts a marked influence on their maturation.

    “This pro-differentiation effect is also in line with the finding that fluoxetine induces the expression of BDNF in dentate gyrus cells, where it exerts a marked influence on their maturation (Molteni et al., 2006;Waterhouse et al., 2012).”

    From Depression and adult neurogenesis: Positive effects of the antidepressant fluoxetine and of physical exercise (2018) · cites this paper as Molteni et al., 2006

    The Results report that chronic fluoxetine increased BDNF mRNA in rat dentate gyrus granule-cell bodies by 15%. The paper does not establish that BDNF exerts a marked influence on those cells’ maturation; its Introduction discusses maturation of midbrain dopaminergic neurons instead. The measured increase was in mRNA, not BDNF protein. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Molteni, R., Calabrese, F., Bedogni, F., Tongiorgi, E., Fumagalli, F., Racagni, G., & Andrea Riva, M.
Affiliations
  • University of Milan (IT)
  • Centro San Giovanni di Dio Fatebenefratelli (IT)
  • University of Trieste (IT)
Venue
The International Journal of Neuropsychopharmacology
Published
2005-07-22
Volume
9
Issue
03
Pages
307
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2150640010
Cited by
132
References
55
Citations by year
2026: 4 · 2025: 7 · 2024: 5 · 2023: 3 · 2022: 10 · 2021: 4 · 2020: 5 · 2019: 8 · 2018: 6 · 2017: 11 · 2016: 4 · 2015: 4 · 2014: 10 · 2013: 6 · 2012: 9
FWCI
4.03
Type
journal article
Language
en
Open access
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
  • INFM-OAR (INFN Catania) (submittedVersion, other-oa)
Funders
Eli Lilly and Company
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Keywords
fluoxetine, brain-derived neurotrophic factor, BDNF mRNA expression, major depressive disorder, antidepressant mechanism, ventral tegmental area, prefrontal cortex, nucleus accumbens shell, hippocampus, neuroplasticity, substantia nigra, striatum
MeSH terms
Animals, Brain, Cytoplasm, Dopamine, Fluoxetine, Gene Expression Regulation, Male, RNA, Messenger, Up-Regulation, Rats, Sprague-Dawley, Brain-Derived Neurotrophic Factor, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review